Literature DB >> 2997988

Isolation and characterization of defective-interfering particles of poliovirus Sabin 1 strain.

S Kajigaya, H Arakawa, S Kuge, T Koi, N Imura, A Nomoto.   

Abstract

Defective-interfering (DI) particles of the Sabin strain of type 1 poliovirus were generated on serial high m.o.i. passaging. The deletions, measured by agarose gel electrophoresis, appeared to comprise approximately 10% of the total genome. Analysis of the RNAs, after digestion with RNase T1, by two-dimensional polyacrylamide gel electrophoresis revealed that the locations of the deleted genome regions were similar to those of the DI particles of the Mahoney strain of type 1 poliovirus (A. Nomoto, A. Jacobson, Y. F. Lee, J. Dunn, and E. Wimmer, (1979), J. Mol. Biol. 128, 179-196). Taking the known nucleotide sequences of the total genome and large RNase T1-resistant oligonucleotides into account, the deletions of almost all DI RNAs were found to exist between nucleotide positions 1307 and 2630, a genome region encoding capsid polypeptides VP2, VP3, and VP1. In cells coinfected with the purified DI particles and the Sabin strain of type 2 or type 3 poliovirus, particles containing the DI genomes were effectively produced. These results suggest that encapsidation signals are conserved in all three serotypes of polioviruses. However, only a very small amount of similar DI particles appeared to be produced in cells coinfected with coxsackie virus B1, although the genomes of polioviruses and coxsackie viruses have common sequences and therefore these viruses are considered to have arisen from a common ancestor. These data may suggest differences in encapsidation signals between polioviruses and coxsackie viruses.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2997988     DOI: 10.1016/0042-6822(85)90339-3

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  23 in total

1.  A poliovirus replicon containing the chloramphenicol acetyltransferase gene can be used to study the replication and encapsidation of poliovirus RNA.

Authors:  N Percy; W S Barclay; M Sullivan; J W Almond
Journal:  J Virol       Date:  1992-08       Impact factor: 5.103

Review 2.  Foot-and-mouth disease.

Authors:  Marvin J Grubman; Barry Baxt
Journal:  Clin Microbiol Rev       Date:  2004-04       Impact factor: 26.132

3.  Evolution of poliovirus defective interfering particles expressing Gaussia luciferase.

Authors:  Yutong Song; Aniko V Paul; Eckard Wimmer
Journal:  J Virol       Date:  2011-12-07       Impact factor: 5.103

4.  Efficient replication of recombinant Enterovirus B types, carrying different P1 genes in the coxsackievirus B5 replicative backbone.

Authors:  Nina Jonsson; Anna Sävneby; Maria Gullberg; Kim Evertsson; Karin Klingel; A Michael Lindberg
Journal:  Virus Genes       Date:  2015-02-08       Impact factor: 2.332

5.  The rhinovirus type 14 genome contains an internally located RNA structure that is required for viral replication.

Authors:  K L McKnight; S M Lemon
Journal:  RNA       Date:  1998-12       Impact factor: 4.942

6.  Interaction of poliovirus with its purified receptor and conformational alteration in the virion.

Authors:  M Arita; S Koike; J Aoki; H Horie; A Nomoto
Journal:  J Virol       Date:  1998-05       Impact factor: 5.103

7.  Characterization of defective viral RNA produced during persistent infection of Vero cells with Murray Valley encephalitis virus.

Authors:  M U Lancaster; S I Hodgetts; J S Mackenzie; N Urosevic
Journal:  J Virol       Date:  1998-03       Impact factor: 5.103

8.  In vitro construction of poliovirus defective interfering particles.

Authors:  K Hagino-Yamagishi; A Nomoto
Journal:  J Virol       Date:  1989-12       Impact factor: 5.103

9.  Genetic variation occurring on the genome of an in vitro insertion mutant of poliovirus type 1.

Authors:  S Kuge; N Kawamura; A Nomoto
Journal:  J Virol       Date:  1989-03       Impact factor: 5.103

10.  Direct interaction between two viral proteins, the nonstructural protein 2C and the capsid protein VP3, is required for enterovirus morphogenesis.

Authors:  Ying Liu; Chunling Wang; Steffen Mueller; Aniko V Paul; Eckard Wimmer; Ping Jiang
Journal:  PLoS Pathog       Date:  2010-08-26       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.